(a) The Board adopts the American Hospital
Formulary Service Pharmacologic-Therapeutic Classification to identify drugs
which the CRNP may prescribe and dispense subject to the parameters identified
in this section.
A CRNP with
current prescriptive authority approval from the Board may prescribe, dispense
and administer drugs and therapeutic or corrective measures consistent with the
prescriptive authority collaborative agreement and relevant to the CRNP's
specialty from the following categories:
(3) Antineoplastic agents,
unclassified therapeutic agents, devices and pharmaceutical aids.
(4) Autonomic drugs.
(5) Blood formation, coagulation and
anticoagulation drugs, and thrombolytic and antithrombolytic agents.
(6) Cardiovascular drugs.
(7) Central nervous system agents.
(8) Contraceptives including foams and
(10) Disinfectants for
agents used on objects other than skin.
(11) Electrolytic, caloric and water
(13) Antitussive, expectorants and mucolytic
(16) Eye, ear, nose
and throat preparations.
Serums, toxoids and vaccines.
Skin and mucous membrane agents.
(19) Smooth muscle relaxants.
(21) Hormones and synthetic
may not prescribe or dispense a drug from the following categories:
(1) Gold compounds.
(2) Heavy metal antagonists.
(3) Radioactive agents.
(5) Schedule I controlled substances as
defined by section 4 of The Controlled Substance, Drug, Device and Cosmetic Act
(35 P. S. §
Restrictions on CRNP
prescribing and dispensing practices are as follows:
(1) A CRNP may write a prescription for a
Schedule II controlled substance for up to a 30-day supply as identified in the
(2) A CRNP
may prescribe a Schedule III or IV controlled substance for up to a 90 day
supply as identified in the collaborative agreement.
(e) A CRNP may not delegate prescriptive